Ann-Christin Mörk

Ann-Christin Mörk has a diverse work experience in the healthcare industry. Ann-Christin is currently working at UCB as the Vice President and Head of Global Patient Centred Outcomes Research, a role they started in April 2022. Prior to this, they held the position of Senior Director and Head of Global Patient Centered Outcomes Research at UCB from April 2019 to April 2022. Before joining UCB, Ann-Christin worked at Clovis Oncology as the Senior Director of European Pricing and Market Access from September 2017 to April 2019. Ann-Christin also has experience at Takeda Pharmaceuticals International GmbH, Nycomed a Takeda Company, Pfizer Sweden, and AstraZeneca, Lund Sweden, where they held various roles in pricing, market access, health economics, and outcomes research.

Ann-Christin Mörk holds a Doctor of Philosophy (PhD) degree from Uppsala University. Ann-Christin also attended Åbo Akademi University, although the specific degree or field of study is unknown.